化合物Cyclo(-RGDfK) TFA T6812L
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
2 mg | 500577-51-5 | ¥562.00 | 询底价 |
1 mg | 500577-51-5 | ¥383.00 | 询底价 |
5 mg | 500577-51-5 | ¥917.00 | 询底价 |
10 mg | 500577-51-5 | ¥1,490.00 | 询底价 |
1 mL | 500577-51-5 | ¥1,590.00 | 询底价 |
50 mg | 500577-51-5 | ¥4,390.00 | 询底价 |
25 mg | 500577-51-5 | ¥2,960.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Cyclo(-RGDfK) TFA
描述: Cyclo(-RGDfK) TFA 是一种选择性整合素αvβ3的有效抑制剂,其IC50值为 0.94 nM。它通过与细胞表面的 αvβ3 整合素结合,特异性靶向肿瘤微血管和癌细胞。
存储条件: keep away from moisturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 100 mg/mL (139.34 mM)
H2O : 33.33 mg/mL (46.44 mM)
关键字: ligand | αvβ3 integrin | Cyclo( RGDfK) TFA | inhibit | Integrin | Microvasculature | cancer | Cyclo(-RGDfK) | Inhibitor | Cyclo(RGDfK) TFA | Cyclo(-RGDfK) TFA | tumoral cell
相关产品: P11 acetate | CWHM-12 | LXW7 | αvβ6 integrin inhibitor 2 | Cyclo(Gly-Arg-Gly-Asp-Ser-Pro) | Lifitegrast | Irigenin | 3-Hydroxyxanthone | RGD | Natalizumab
相关库: Cyclic Peptide Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Macrocyclic Compound Library | Inhibitor Library | Peptide Compound Library | Cytoskeletal Signaling Pathway Compound Library | Anti-Cancer Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物Cyclo(-RGDfK) TFA T6812L信息由TargetMol中国为您提供,如您想了解更多关于化合物Cyclo(-RGDfK) TFA T6812L报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途